Sector News

ALTANA Management Board Repositions Itself for the Future

June 26, 2015
Energy & Chemical Value Chain
The Supervisory Board of the specialty chemicals company ALTANA has appointed Martin Babilas (43) to become the Chief Executive Officer. On January 1, 2016, he will succeed Dr. Matthias L. Wolfgruber (61), who will retire. Martin Babilas has been the Chief Financial Officer of ALTANA AG since 2007. In November of last year, he took over additional responsibility of two of the company’s four divisions from Dr. Wolfgruber. Babilas has worked for ALTANA since 1998.
 
“The generation change in the company’s management reflects sustainable corporate development, as well as the Group’s ability to change,” said Dr. Klaus-Jurgen Schmieder, Chairman of the Supervisory Board of ALTANA AG. “Under the leadership of Dr. Wolfgruber, ALTANA’s chemical business has developed extraordinarily successfully in the last 13 years while undergoing constant changes. We would like to express our sincere gratitude and great appreciation for him already today. As a longtime member of the Management Board, Martin Babilas has played a key role in the development of ALTANA’s strategy. We are convinced that he will continue to lead the company on this successful path.”
 
The Supervisory Board has appointed Stefan Genten (46) as ALTANA’s new Chief Financial Officer as of August 1, 2015. Stefan Genten worked in various management capacities for the Grunenthal pharmaceutical group for 13 years, since 2005 as a member of the Corporate Executive Board and as the CFO. He was also in charge of operative functions, for example for the Latin American business, and as Group Chief Operating Officer (COO) for the last five years.
 
“We are pleased to have attracted Stefan Genten, a proven leadership personality, to ALTANA,” said Dr. Schmieder about the new CFO. “He will provide us with new impetus and we will benefit from his many years of international experience.”
 
On January 1, 2016, Martin Babilas will take over responsibility for Corporate Development/M&A, Human Resources, Corporate Communications and Internal Audit from Dr. Wolfgruber. On that same date, Dr. Christoph Schlunken (53) will assume responsibility for Innovation Management. Dr. Schlunken became a third member of ALTANA’s Management Board last November.
 
Source: ALTANA

comments closed

Related News

March 24, 2024

Thomas Gangl leaves Borealis

Energy & Chemical Value Chain

Appointed Borealis CEO in 2021, Thomas has led key initiatives including the sale of the nitrogen business, acquisitions of Rialti Spa and Integra Plastics AD, and Borouge’s IPO. He also made the final investment decision for the Borouge 4 plant, set to be the world’s largest polyolefin complex.

March 24, 2024

Chemours names Dignam permanent CEO

Energy & Chemical Value Chain

The Chemours Co. today named interim CEO Denise Dignam as the company’s permanent CEO and president, as well as a member of the board of directors, effective immediately. Dignam has been interim CEO since late February, when former CEO Mark Newman was placed on leave due to an internal investigation.

March 24, 2024

Neste merges three business lines into new Renewable Products unit

Energy & Chemical Value Chain

Neste Corp. (Espoo, Finland) has completed its organizational change process, announced on 1 November 2023. Neste informed that it will merge its three renewable business units into one Renewable Products business unit as well as restructure its functions to better support business-driven ways of working.

How can we help you?

We're easy to reach